journal
MENU ▼
Read by QxMD icon Read
search

Drug and Therapeutics Bulletin

journal
https://www.readbyqxmd.com/read/29980592/correction-an-update-on-the-management-of-gout
#1
(no author information available yet)
No abstract text is available yet for this article.
July 6, 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30008443/ocrelizumab-for-multiple-sclerosis
#2
(no author information available yet)
▼Ocrelizumab (Ocrevus - Roche Registration GmbH) has received marketing authorisation approval from the European Medicines Agency (EMA) for the treatment of adults with multiple sclerosis.1,2 It is the first drug to be licensed for use in early primary progressive multiple sclerosis and relapsing forms of multiple sclerosis. Here, we review the evidence for the safety and effectiveness of ocrelizumab.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30008442/what-role-for-metformin-in-type-1-diabetes
#3
(no author information available yet)
Tight glycaemic control is key to reducing the risk of cardiovascular and microvascular complications in people with type 1 diabetes.1 Standard treatment involves optimising insulin therapy to achieve an HbA1c level of 48mmol/mol (6.5%) or lower. Although not licensed for use in type 1 diabetes, metformin is included in some clinical guidelines as adjuvant therapy for people with type 1 diabetes who are overweight and wish to improve glycaemic control while minimising the dose of insulin.1,2 The REMOVAL study is the largest trial to date that has investigated the longer-term effects of metformin in people with type 1 diabetes...
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29976835/managing-the-risk-from-interactions-with-herbal-medicines
#4
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970589/little-evidence-that-antidepressants-are-effective-for-insomnia
#5
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970588/impact-of-screening-on-chlamydia-infections
#6
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970587/recent-opioid-use-associated-with-increased-risk-of-falls-in-older-people
#7
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970586/european-medicines-agency-reviews-dosing-errors-with-methotrexate
#8
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970585/exercise-for-people-with-hip-and-knee-osteoarthritis
#9
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970584/non-research-payments-to-physicians-associated-with-more-opioid-prescriptions-in-the-usa
#10
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29970583/emollient-bath-additives-for-eczema-add-no-benefit
#11
(no author information available yet)
No abstract text is available yet for this article.
July 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29903753/what-dose-of-paracetamol-for-older-people
#12
(no author information available yet)
Paracetamol, on its own or in combination with other analgesics, is widely used to treat pain associated with acute and chronic conditions. It is considered safe enough to have a general sales licence (GSL) for use by "adults, elderly and children over 16 years" and has few listed cautions or contraindications.1,2 However, recently the effectiveness and safety of paracetamol for some conditions have been challenged, 3,4 and there are published case reports of liver failure associated with therapeutic doses...
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29903752/what-place-is-there-for-tramadol-dexketoprofen
#13
(no author information available yet)
No single analgesic provides effective pain relief in all patients and increasing the dose of an analgesic may increase its unwanted effects.1 In addition, pain frequently results from multiple mechanisms that may respond to different pharmacological interventions.2 One suggested approach is to combine analgesics with different modes of action, with the aim of delivering better analgesia using lower doses of each drug.1 Skudexa (A. Menarini Farmaceutica Internazionale SRL), a combination of tramadol hydrochloride (a synthetic opioid analgesic that is a partial agonist at the μ, δ and κ opioid receptors) and dexketoprofen (a NSAID), is licensed for short term treatment of moderate to severe acute pain in adults...
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29880701/there-is-no-news
#14
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875174/nhs-england-s-do-not-prescribe-list
#15
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875173/guidance-on-management-of-otitis-media-in-children
#16
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875172/risk-of-burns-with-flammable-treatments-for-head-lice
#17
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875171/safety-alert-change-of-colour-for-fast-acting-insulin-%C3%A2-fiasp-products
#18
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875170/antenatal-fetal-rhesus-d-testing
#19
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29875169/cardiovascular-safety-of-febuxostat-and-allopurinol
#20
(no author information available yet)
No abstract text is available yet for this article.
June 2018: Drug and Therapeutics Bulletin
journal
journal
21685
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"